omniture
HYUNDAI BIOSCIENCE

Latest News

A 'Game Changer' COVID-19 drug from Korea was introduced in a world class academic journal

SEOUL South Korea, May 23, 2021 /PRNewswire/ -- Hyundai Bioscience (KOSDAQ 048410) announced on the...

2021-05-24 08:16 1464

An oral antiviral drug from Korea may be a problem solver for COVID-19

SEOUL, South Korea, May 13, 2021 /PRNewswire/ -- Hyundai Bioscience (KOSDAQ 048410) announced that ...

2021-05-13 16:37 1476

CNPharm has succeeded in maintaining IC100 for 24 hours with one injection

- Trail-blazing diversification of the repurposing of Niclosamide - Full-scale clinical preparation ...

2021-04-19 20:15 1342

Hyundai Bioscience leads in the repurposing of Niclosamide

SEOUL, South Korea, April 8, 2021 /PRNewswire/ -- A research paper by a South Korean bio tech compa...

2021-04-08 17:17 1663

Hyundai Bioscience Develops Injection Drug for Potential Treatment of Severe Cases of COVID-19

SEOUL, South Korea, Dec. 22, 2020 /PRNewswire/ -- Hyundai Bioscience (KOSDAQ symbol: 048410) announ...

2020-12-23 10:09 1439

Hyundai Bioscience announced that its COVID-19 oral drug solved Niclosamide's inhibitory concentration problem

SEOUL, South Korea, Dec. 8, 2020 /PRNewswire/ -- Hyundai Bioscience (KOSDAQ symbol: 048410) release...

2020-12-08 21:00 1128

Hyundai Bioscience: A Korean bio-tech solves the bioavailability issue of Niclosamide

SEOUL, South Korea, Oct. 29, 2020 /PRNewswire/ -- Expectations are increasing as a Korean bio-tech ...

2020-10-29 20:00 7081

'Curing Cancer without Surgery'

* "Successful disappearance of tumors in subjects upon administering the pain-free anticancer dru...

2020-06-30 15:10 1272